Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA).

ABSTRACT:

Background

This study aimed to describe treatment patterns in patients with myasthenia gravis (MG) in France.

Methods

A retrospective cohort analysis was performed using the French National Health Data System (SNDS) database between 2008 and 2019. MG patients were identified using ICD-10 codes during hospitalization and/or long-term disease. We defined two adult subpopulations: a prevalent MG population of patients alive on 31/12/2019 and an incident population of newly identified patients with MG in 2012 and 2013.

Results

Among the 22,079 prevalent patients, 53.1% (n = 11,498) received at least one chronic MG treatment in 2019. Among these treated patients, 52.5% received Acetylcholinesterase inhibitors (AChEIs) only, 10.2% were treated with corticosteroids (CS) ± AC

SUBMITTER: Tard C 

PROVIDER: S-EPMC11561051 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature